xcube.bio invests capital, knowledge and capabilities in the European and Canadian market entry of late-stage Biopharma, with the objective to create partners' own commercial footprint and revenue streams. 

We have a unique NewCo partnership approach. We are invested in the success of the European and Canadian market-entry alongside the biopharma partner.

We are a particularly attractive solution for emerging biopharmas, first time launchers, with novels mode of action, platform or multi-indication therapies, addressing rare or niche disease areas